Cargando…
Deciphering the vedolizumab dosing conundrum in IBD: when less is more
Autores principales: | Adolph, Timon Erik, Siegmund, Britta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279744/ https://www.ncbi.nlm.nih.gov/pubmed/34497148 http://dx.doi.org/10.1136/gutjnl-2021-325893 |
Ejemplares similares
-
Commentary: When is less more?
por: Sinha, Pranava
Publicado: (2021) -
Epithelial RAC1 niches in IBD: from barrier integrity to cytoskeletal plasticity
por: Haag, Lea-Maxie, et al.
Publicado: (2023) -
COVID-19: When more might be less
por: Mugnai, Giacomo, et al.
Publicado: (2021) -
Gastrointestinal endoscopy during COVID-19: when less is more
por: Edwards, Cathryn, et al.
Publicado: (2020) -
The dosing conundrum of emicizumab: To waste product or not?
por: Young, Guy
Publicado: (2023)